Regarding fibrotic progression, CD68 alone demonstrated excellent diagnostic accuracy for secondary myelofibrosis prediction, with an AUC of 0.851 (p < 0.001), achieving a specificity of 100% at a cutoff of less than 27.5. Here, CD68 is linked to myelofibrosis.